CA-125 reduction during neoadjuvant chemotherapy is associated with success of cytoreductive surgery and outcome of patients with advanced high-grade ovarian cancer.

Kessous, Roy; Wissing, Michel D; Piedimonte, Sabrina; Abitbol, Jeremie; Kogan, Liron; Laskov, Ido; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H

Kessous, Roy; Wissing, Michel D; Piedimonte, Sabrina; Abitbol, Jeremie; Kogan, Liron; Laskov, Ido; Yasmeen, Amber; Salvador, Shannon; Lau, Susie; Gotlieb, Walter H.

Afiliación

Kessous R; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Wissing MD; Department of Oncology, McGill University, Montreal, QC, Canada.
Piedimonte S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Abitbol J; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Kogan L; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Laskov I; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Yasmeen A; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Salvador S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Lau S; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Gotlieb WH; Division of Gynecologic Oncology, Segal Cancer Center, Jewish General Hospital, McGill University, Montreal, QC, Canada.

Acta Obstet Gynecol Scand ; 99(7): 933-940, 2020 07.

Article en En | MEDLINE | ID: mdl-31954071

Asunto(s)

Antígeno Ca-125/metabolismo; Procedimientos Quirúrgicos de Citorreducción; Neoplasias Ováricas/tratamiento farmacológico; Neoplasias Ováricas/cirugía; Anciano; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico; Biomarcadores de Tumor/metabolismo; Femenino; Humanos; Persona de Mediana Edad; Terapia Neoadyuvante; Clasificación del Tumor; Estadificación de Neoplasias; Neoplasias Ováricas/mortalidad; Quebec; Estudios Retrospectivos; Tasa de Supervivencia

Palabras clave

CA-125; advanced ovarian cancer; neoadjuvant chemotherapy; primary debulking surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antígeno Ca-125 / Procedimientos Quirúrgicos de Citorreducción Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Acta Obstet Gynecol Scand Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google